BIOMERIEUX (BMXMF:OTCMKTS)
$105.41 2 (1.934%)
Analysed BIOMERIEUX (BMXMF:OTCMKTS) News Sources
BioMerieux SA (BMXMF) Full Year 2025 Earnings Call Highlights: Strong Organic Growth and ...
27-02-2026
yahoo.com
bioMérieux launches SMARTBIOME™ to help food manufacturers gain deeper insights into spoilage and protect product quality
18-02-2026
yahoo.com
Commonwealth Fusion Systems Names Stephane Bancel to Board of Directors
12-01-2026
yahoo.com
Clinical Microbiology Market Set to Reach USD 7.4 Billion by 2032, Driven by Advancements in Diagnostics and Rising Infectious Disease Rates – SNS Insider
28-10-2025
yahoo.com
bioMerieux Product Pipeline and Strategy Analysis Report, 2025
21-10-2025
yahoo.com
Should Altesa BioSciences’ Use of SPOTFIRE Shift bioMérieux’s (ENXTPA:BIM) Diagnostic Market Position?
17-09-2025
yahoo.com
OhioHealth Partners with bioMérieux as Newest Global Antimicrobial Stewardship Center of Excellence
26-08-2025
yahoo.com
bioMérieux Develops Game Changing Quality Control Solution GENE-UP® PRO HRM
05-08-2025
yahoo.com
Saudi Arabia In-Vitro Diagnostics Market Report 2025-2030 Featuring Abbott, BD, Bio-Rad Laboratories, Biomerieux, Danaher, Nihon Kohden, Roche, Siemens Healthineers, Sysmex, Thermo Fischer Scientific
16-07-2025
yahoo.com
What is the current price of BIOMERIEUX (BMXMF:OTCMKTS)?
The current price of BIOMERIEUX (BMXMF:OTCMKTS) is $105.41.
BIOMERIEUX (BMXMF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of BIOMERIEUX (BMXMF:OTCMKTS) since the previous trading day is $2.
BIOMERIEUX (BMXMF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of BIOMERIEUX (BMXMF:OTCMKTS) since the previous trading day is 1.934%.
What is the most recent average sentiment score for BIOMERIEUX (BMXMF:OTCMKTS)?
The most recent average sentiment score for BIOMERIEUX (BMXMF:OTCMKTS) is 88 out of 100.
What is the most recent average sentiment for BIOMERIEUX (BMXMF:OTCMKTS)?
The most recent sentiment for BIOMERIEUX (BMXMF:OTCMKTS) is .
SEC-8K** Filing Available For BIOMERIEUX (BMXMF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.